Improved response to electroconvulsive therapy after switching from haloperidol to blonanserin in a patient with treatment-resistant schizophrenia.

Takahashi, Kazuhito; Yokotsuka-Ishida, Saeko; Nakamura, Toshinori; Sasayama, Daimei; Washizuka, Shinsuke

Takahashi, Kazuhito; Yokotsuka-Ishida, Saeko; Nakamura, Toshinori; Sasayama, Daimei; Washizuka, Shinsuke.

Afiliação

Takahashi K; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
Yokotsuka-Ishida S; Department of Psychiatry, Ritsuzankai Iida Hospital, Iida, Japan.
Nakamura T; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
Sasayama D; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.
Washizuka S; Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan.

Psychiatry Clin Neurosci ; 76(3): 91-93, 2022 Mar.

Article em En | MEDLINE | ID: mdl-34921693

Assuntos

Antipsicóticos; Eletroconvulsoterapia; Esquizofrenia; Antipsicóticos/farmacologia; Antipsicóticos/uso terapêutico; Haloperidol/farmacologia; Haloperidol/uso terapêutico; Humanos; Piperazinas; Piperidinas; Esquizofrenia/tratamento farmacológico; Esquizofrenia Resistente ao Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Eletroconvulsoterapia Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google